Roche Holding AG
SIX:ROG
Roche Holding AG
Operating Income
Roche Holding AG
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Roche Holding AG
SIX:ROG
|
Operating Income
CHf19.2B
|
CAGR 3-Years
0%
|
CAGR 5-Years
1%
|
CAGR 10-Years
1%
|
|
Novartis AG
SIX:NOVN
|
Operating Income
$12.6B
|
CAGR 3-Years
1%
|
CAGR 5-Years
5%
|
CAGR 10-Years
1%
|
|
NLS Pharmaceutics AG
NASDAQ:NLSP
|
Operating Income
$-15.5m
|
CAGR 3-Years
-54%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
N/A
|
|
S
|
Sandoz Group AG
SIX:SDZ
|
Operating Income
$1.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Roche Holding AG's Operating Income?
Operating Income
19.2B
CHF
Based on the financial report for Dec 31, 2023, Roche Holding AG's Operating Income amounts to 19.2B CHF.
What is Roche Holding AG's Operating Income growth rate?
Operating Income CAGR 10Y
1%
Over the last year, the Operating Income growth was -4%.